BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 23994188)

  • 1. Anti-hepatitis C virus RdRp activity and replication of novel anilinobenzothiazole derivatives.
    Peng HK; Chen WC; Lin YT; Tseng CK; Yang SY; Tzeng CC; Lee JC; Yang SC
    Antiviral Res; 2013 Oct; 100(1):269-75. PubMed ID: 23994188
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A fluorescence-based high-throughput screen to identify small compound inhibitors of the genotype 3a hepatitis C virus RNA polymerase.
    Eltahla AA; Lackovic K; Marquis C; Eden JS; White PA
    J Biomol Screen; 2013 Oct; 18(9):1027-34. PubMed ID: 23708123
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Substituted 2,6-bis(benzimidazol-2-yl)pyridines: a novel chemical class of pestivirus inhibitors that targets a hot spot for inhibition of pestivirus replication in the RNA-dependent RNA polymerase.
    Musiu S; Pürstinger G; Stallinger S; Vrancken R; Haegeman A; Koenen F; Leyssen P; Froeyen M; Neyts J; Paeshuyse J
    Antiviral Res; 2014 Jun; 106():71-9. PubMed ID: 24680957
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Discovery of novel tricyclic indole derived inhibitors of HCV NS5B RNA dependent RNA polymerase.
    Venkatraman S; Velazquez F; Gavalas S; Wu W; Chen KX; Nair AG; Bennett F; Huang Y; Pinto P; Jiang Y; Selyutin O; Vibulbhan B; Zeng Q; Lesburg C; Duca J; Huang HC; Agrawal S; Jiang CK; Ferrari E; Li C; Kozlowski J; Rosenblum S; Shih NY; Njoroge FG
    Bioorg Med Chem; 2013 Apr; 21(7):2007-17. PubMed ID: 23434368
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Resistance to HCV nucleoside analogue inhibitors of hepatitis C virus RNA-dependent RNA polymerase.
    Najera I
    Curr Opin Virol; 2013 Oct; 3(5):508-13. PubMed ID: 24070806
    [TBL] [Abstract][Full Text] [Related]  

  • 6. RNA dependent RNA polymerase of HCV: a potential target for the development of antiviral drugs.
    Waheed Y; Bhatti A; Ashraf M
    Infect Genet Evol; 2013 Mar; 14():247-57. PubMed ID: 23291407
    [TBL] [Abstract][Full Text] [Related]  

  • 7. B-ring modified aurones as promising allosteric inhibitors of hepatitis C virus RNA-dependent RNA polymerase.
    Meguellati A; Ahmed-Belkacem A; Yi W; Haudecoeur R; Crouillère M; Brillet R; Pawlotsky JM; Boumendjel A; Peuchmaur M
    Eur J Med Chem; 2014 Jun; 80():579-92. PubMed ID: 24835816
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Non-nucleoside inhibitors of the HCV polymerase.
    Sarisky RT
    J Antimicrob Chemother; 2004 Jul; 54(1):14-6. PubMed ID: 15190019
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Selective inhibitors of hepatitis C virus replication.
    Neyts J
    Antiviral Res; 2006 Sep; 71(2-3):363-71. PubMed ID: 16843538
    [TBL] [Abstract][Full Text] [Related]  

  • 10. New pseudodimeric aurones as palm pocket inhibitors of Hepatitis C virus RNA-dependent RNA polymerase.
    Meguellati A; Ahmed-Belkacem A; Nurisso A; Yi W; Brillet R; Berqouch N; Chavoutier L; Fortuné A; Pawlotsky JM; Boumendjel A; Peuchmaur M
    Eur J Med Chem; 2016 Jun; 115():217-29. PubMed ID: 27017550
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Discovery of Potent Non-nucleoside Inhibitors of Dengue Viral RNA-Dependent RNA Polymerase from Fragment Screening and Structure-Guided Design.
    Lim SP; Noble CG; Nilar S; Shi PY; Yokokawa F
    Adv Exp Med Biol; 2018; 1062():187-198. PubMed ID: 29845534
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A 7-deaza-adenosine analog is a potent and selective inhibitor of hepatitis C virus replication with excellent pharmacokinetic properties.
    Olsen DB; Eldrup AB; Bartholomew L; Bhat B; Bosserman MR; Ceccacci A; Colwell LF; Fay JF; Flores OA; Getty KL; Grobler JA; LaFemina RL; Markel EJ; Migliaccio G; Prhavc M; Stahlhut MW; Tomassini JE; MacCoss M; Hazuda DJ; Carroll SS
    Antimicrob Agents Chemother; 2004 Oct; 48(10):3944-53. PubMed ID: 15388457
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A pyrazolotriazolopyrimidinamine inhibitor of bovine viral diarrhea virus replication that targets the viral RNA-dependent RNA polymerase.
    Paeshuyse J; Letellier C; Froeyen M; Dutartre H; Vrancken R; Canard B; De Clercq E; Gueiffier A; Teulade JC; Herdewijn P; Puerstinger G; Koenen F; Kerkhofs P; Baraldi PG; Neyts J
    Antiviral Res; 2009 Jun; 82(3):141-7. PubMed ID: 19428605
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A homogeneous, solid-phase assay for hepatitis C virus RNA-dependent RNA polymerase.
    Wang YK; Rigat KL; Roberts SB; Gao M
    Anal Biochem; 2006 Dec; 359(1):106-11. PubMed ID: 17054898
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Highly potent and selective inhibition of bovine viral diarrhea virus replication by γ-carboline derivatives.
    Salim MT; Goto Y; Hamasaki T; Okamoto M; Aoyama H; Hashimoto Y; Musiu S; Paeshuyse J; Neyts J; Froeyen M; Herdewijn P; Baba M
    Antiviral Res; 2010 Dec; 88(3):263-8. PubMed ID: 20869990
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization of the inhibition of hepatitis C virus RNA replication by nonnucleosides.
    Tomei L; Altamura S; Bartholomew L; Bisbocci M; Bailey C; Bosserman M; Cellucci A; Forte E; Incitti I; Orsatti L; Koch U; De Francesco R; Olsen DB; Carroll SS; Migliaccio G
    J Virol; 2004 Jan; 78(2):938-46. PubMed ID: 14694125
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Broad-spectrum non-nucleoside inhibitors for caliciviruses.
    Netzler NE; Enosi Tuipulotu D; Eltahla AA; Lun JH; Ferla S; Brancale A; Urakova N; Frese M; Strive T; Mackenzie JM; White PA
    Antiviral Res; 2017 Oct; 146():65-75. PubMed ID: 28757394
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Understanding hepatitis C viral dynamics with direct-acting antiviral agents due to the interplay between intracellular replication and cellular infection dynamics.
    Guedj J; Neumann AU
    J Theor Biol; 2010 Dec; 267(3):330-40. PubMed ID: 20831874
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficient in silico assay of inhibitors of hepatitis C Virus RNA-dependent RNA polymerase by structure-based virtual screening and in vitro evaluation.
    Lin YT; Huang KJ; Tseng CK; Chen KJ; Wang HM; Lee JC
    Assay Drug Dev Technol; 2011 Jun; 9(3):290-8. PubMed ID: 21281131
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular mechanism of a thumb domain hepatitis C virus nonnucleoside RNA-dependent RNA polymerase inhibitor.
    Howe AY; Cheng H; Thompson I; Chunduru SK; Herrmann S; O'Connell J; Agarwal A; Chopra R; Del Vecchio AM
    Antimicrob Agents Chemother; 2006 Dec; 50(12):4103-13. PubMed ID: 16940072
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.